Prelude Therapeutics Inc - COM (PRLD)

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
33.9 M
Holdings value Q1 2024
$161 M
Value change Q1 2024
-$2.3 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
53
Number of buys Q1 2024
22
Number of sells Q1 2024
-23
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
74065P101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 33.9 M $161 M -$2.3 M $4.74 53
2023 Q4 34.4 M $147 M -$6.55 M $4.27 54
2023 Q3 36.6 M $113 M +$1.04 M $3.09 57
2023 Q2 36.3 M $163 M +$31.3 M $4.50 52
2023 Q1 31.5 M $180 M +$1.73 M $5.70 52
2022 Q4 31.2 M $188 M -$4.39 M $6.04 57
2022 Q3 31.8 M $210 M -$5.2 M $6.61 48
2022 Q2 32.2 M $168 M -$6.71 M $5.22 51
2022 Q1 32.5 M $224 M -$9.98 M $6.90 60
2021 Q4 35.1 M $437 M -$27.3 M $12.45 71
2021 Q3 35.9 M $1.12 B +$46.3 M $31.25 59
2021 Q2 34.5 M $987 M +$53.3 M $28.63 57
2021 Q1 32.5 M $1.41 B -$97.8 M $43.33 59
2020 Q4 34.7 M $2.47 B +$136 M $71.55 50
2020 Q3 33.3 M $1 B +$1 B $30.13 38